US EditionPublished • loading... • Updated
Recipharm Advanced Bio Partners with Infant Bacterial Therapeutics for Commercial Drug Production
Recipharm Advanced Bio, a segment of CDMO Recipharm, and Infant Bacterial Therapeutics (IBT) began a process performance qualification (PPQ) for IBT’s lead product, IBP-9414. The PPQ program will take place at Recipharm’s microbial manufacturing facility in Cuxhaven, Germany. “By combining IBT’s innovative approach with Recipharm Advanced Bio’s microbial expertise and accelerated path to manufacturing, we are ensuring PPQ and commercial readines…
1 Articles
1 Articles
Recipharm Advanced Bio Partners with Infant Bacterial Therapeutics for Commercial Drug Production
Recipharm Advanced Bio, a segment of CDMO Recipharm, and Infant Bacterial Therapeutics (IBT) began a process performance qualification (PPQ) for IBT’s lead product, IBP-9414. The PPQ program will take place at Recipharm’s microbial manufacturing facility in Cuxhaven, Germany. “By combining IBT’s innovative approach with Recipharm Advanced Bio’s microbial expertise and accelerated path to manufacturing, we are ensuring PPQ and commercial readines…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
